About

Kinomica aims to improve patient outcomes by introducing disruptive technologies for companion diagnostics (CDx) and therapeutic development in precision medicine. Our flagship KinoScanTM innovation – based on advanced phosphoproteomics and proprietary bioinformatics and machine learning algorithms – enables a new generation of game-changing biomarker diagnostics with clear advantages over current state-of-the-art CDx based on genetic mutation.

www.kinomica.com
Loading...
Processing. Please wait.
Loading...